Invesco
MBOT icon

Invesco’s Microbot Medical MBOT Stock Holding History

Invesco’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70.9K Buy
29,420
+4,908
+20% +$11K ﹤0.01% 3663
2025
Q4 		$49K Buy
+24,512
New +$58.1K ﹤0.01% 3706
2018
Q3 		– Sell
-828
Closed -$9K – 3905
2018
Q2 		$9K Buy
+828
New +$10.1K ﹤0.01% 3852

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Invesco's MBOT Position: Q1 2026 in Review

Invesco increased its Microbot Medical (MBOT) stake by 20% in Q1 2026, buying an estimated $11K and bringing the position to 29,420 shares worth $70.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3663.

Invesco first reported a position in MBOT in Q2 2018 and has held it in 3 quarters since. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Invesco held 29,420 shares of Microbot Medical worth $70.9K as of Q1 2026.
  • Invesco bought 4,908 Microbot Medical shares in Q1 2026, an estimated $11K.
  • Microbot Medical made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3663 holding.
  • Invesco first reported a position in Microbot Medical in Q2 2018 and has held it in 3 quarters since.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.